Peptides
Last Updated
Jun 9, 2026
Table of contents
Search "peptides for muscle growth" and you get a tidy list of compounds promising steroid-like gains with none of the downside. The reality is messier and worth understanding before you spend a dollar. Most of these are not approved medicines. They are research chemicals with thin human evidence, and a couple carry real safety problems.
This guide covers the five most commonly pushed muscle peptides honestly: what each actually does, what the evidence shows, what the risks are, and whether you can legally get it. The short version is that none of them is a shortcut, a few of them are a genuinely bad idea, and the things that actually build muscle are not on the list. We will get to those too.
The numbers
The honest starting point.
Set expectations first
What actually builds muscle.
Before any compound, the honest hierarchy. The overwhelming majority of muscle growth comes from progressive resistance training, enough protein, enough sleep, and enough time. That is not a disclaimer to skip past, it is the part that does ninety-plus percent of the work, and no peptide changes it. The next most reliable lever is correcting a genuine deficiency, most commonly clinically low testosterone, under medical supervision. That is real medicine with real monitoring, and it is a different thing entirely from the list below.
The muscle peptides themselves nearly all funnel through one pathway: raise growth hormone, which raises IGF-1, which has a role in muscle protein synthesis and recovery. The mechanism is real. The problem is that the human evidence for these specific compounds building meaningful muscle in healthy, training adults is limited, most are research chemicals rather than approved or compounded therapeutics, and the same IGF-1 signal that grows muscle also raises real safety questions. Read the rankings with that in mind.
The honest landscape
Evidence vs. legitimacy.
Muscle peptides plotted by how strong the human evidence is against how legitimate and accessible they are. Nothing reaches the top. The real driver, training plus protein plus sleep, sits top right for reference and is not a peptide. CJC-1295 is the least unreasonable option and is pending the July 2026 review. The rest are research chemicals, and ACE-031 had its trials halted for safety.
At a glance
Five peptides, ranked honestly.
| Rank | Peptide | Class | What it does | Evidence | Status |
|---|---|---|---|---|---|
| 1 | CJC-1295 GHRH analog | GH-axis | Recovery, modest body composition | Limited | Pending Jul 2026 |
| 2 | IGF-1 LR3 IGF-1 analog | IGF-1 receptor | Anabolic signal, broad cell growth | Limited | Research only |
| 3 | PEG-MGF IGF-1 splice variant | Repair signal | Satellite cell and repair theory | Emerging | Research only |
| 4 | GHRP-6 GH secretagogue | Ghrelin / GH | Big appetite boost, some GH | Limited | Research only |
| 5 | ACE-031 Myostatin trap | Myostatin | Removes a brake on muscle size | Emerging | Halted in trials |
Ranking reflects the balance of mechanism, human evidence, safety, and whether the compound is a legitimate product at all. The order is least-bad to worst, not a list of recommendations.
In depth
The peptides, one by one.
CJC-1295
CJC-1295 is a long-acting analog of growth-hormone-releasing hormone that prompts your pituitary to release more of your own growth hormone, which in turn raises IGF-1. For muscle the theory is better recovery, better sleep, and a modest anabolic nudge. In practice the controlled evidence that it builds meaningful muscle in healthy, training adults is limited, and the realistic effect is on recovery and body composition at the edges rather than dramatic size.
IGF-1 LR3
IGF-1 LR3 is a long-acting version of insulin-like growth factor 1, the hormone downstream of growth hormone that binds receptors on essentially every cell to drive growth. That is exactly why it is popular in bodybuilding and exactly why it is risky. The same signal that grows muscle drives cell proliferation broadly, and elevated IGF-1 is associated with increased risk of several cancers. It can also drop blood sugar sharply.
PEG-MGF
PEG-MGF is a pegylated version of mechano-growth factor, a splice variant of IGF-1 released in muscle after mechanical stress that is thought to help activate satellite cells and aid repair. The recovery logic is plausible, but the human evidence is preclinical and thin, and it only has a rationale at all if you are already training hard enough to create the damage it is meant to help repair.
GHRP-6
GHRP-6 is a growth-hormone-releasing peptide that works through the ghrelin receptor, so alongside a growth hormone bump it produces a strong increase in appetite. For someone struggling to eat enough in a bulk, that appetite effect is the real draw, but it is an eating aid more than a muscle-building mechanism, and the direct evidence for added muscle is limited.
ACE-031
ACE-031 is a myostatin trap, a fusion protein designed to soak up myostatin, the body's brake on muscle growth, which can increase muscle size. The mechanism is genuinely powerful, but its clinical development was stopped over safety signals including bleeding and small-vessel problems, and reports suggest it adds size more than usable strength. It now exists mainly as a gray-market research chemical.
The mechanism
How they are supposed to work.
Almost all of these run through the same chain. Raising growth hormone, whether with a GHRH analog like CJC-1295 or a secretagogue like GHRP-6, raises IGF-1, and IGF-1 supports muscle protein synthesis and recovery through well-mapped signaling pathways. IGF-1 analogs like IGF-1 LR3 and PEG-MGF skip a step and act on that receptor directly. ACE-031 takes a different route, removing myostatin so the body's natural limit on muscle size loosens.
The pathways are real, which is why the marketing sounds convincing. What the marketing leaves out is that a real mechanism in a petri dish or a clinical population does not equal a safe, proven result for a healthy adult chasing gym gains. The evidence gap, the safety questions, and the legal status are where these fall down, not the biochemistry.
The honest answer
Are they worth it?
For almost everyone, no. None of these is approved for building muscle, the human evidence ranges from limited to preclinical, several are research chemicals of unknown purity, one had its trials stopped for safety, and the IGF-1 route carries a real cancer concern. Even taken at their best, the realistic upside is a modest edge on recovery and body composition, not the steroid-adjacent transformation the marketing implies.
The honest path to more muscle is unglamorous and reliable: train hard with progressive overload, eat enough protein, sleep, stay consistent for longer than feels reasonable, and if something is genuinely off, get it measured and treat the real cause under medical care. That last part is where a peptide or a hormone can occasionally belong, but only as a supervised correction of a real deficiency, not as a research chemical bought on a hunch.
The part that actually matters
Measure before you experiment.
If you are training and eating well and still not building muscle, the high-yield move is not a research chemical. It is finding out why. Low testosterone, a thyroid problem, low vitamin D, poor sleep quality, and chronic under-recovery all blunt muscle growth, and all of them show up in data you can actually measure. Correcting a genuine deficiency under a clinician does more, and far more safely, than anything on this list.
That is what OneTwenty is built to do. Quarterly comprehensive panels, continuous data from your connected devices, and an AI coaching layer that reads it together, with treatment, where it is warranted, handled by independent licensed providers and tracked against your numbers. The goal is to fix the thing that is actually holding you back, not to gamble on a vial with no human safety data.
How to approach it
A sensible way to think about it.
Build the base first
Progressive training, enough protein, and enough sleep do almost all of the work. If those are not dialed in, no peptide will save you, and you will not be able to tell what, if anything, is even working.
Test before you chase
Testosterone, IGF-1, thyroid, vitamin D, and basic metabolic markers explain a lot of stalled progress. Find the real bottleneck before reaching for a compound.
Treat real deficiencies under care
Clinically low testosterone, for example, is a legitimate, monitored medical intervention. That is a different universe from a research chemical bought online, and it is the right place to start.
Avoid anything with no human safety data or halted trials
IGF-1 analogs carry a cancer-promotion concern, and ACE-031's own trials were stopped for safety. A compound that could not clear its own studies is not a smart shortcut.
Treat "milder than steroids" as a sales pitch
It is a framing, not a safety guarantee. Unapproved, unmonitored compounds are not safe by virtue of being peptides.
Fix the bottleneck
Find what is actually holding your progress back.
OneTwenty launches in June 2026 with comprehensive testing, quarterly panels, connected device data, and clinician-supervised care, so the things that quietly limit muscle growth, low testosterone, thyroid issues, poor recovery, get measured and addressed instead of guessed at. Join the beta for early access.
Join the betaComprehensive testing · quarterly panels · clinician-supervised · $499/yr
Common questions
Muscle peptides, answered.
Do peptides actually build muscle?
At best, modestly, and mostly by supporting growth hormone, IGF-1, and recovery rather than directly adding size. The human evidence for these specific compounds is limited, and none replaces training, protein, and sleep. Most of the visible "results" online come from people who also train and eat seriously.
Are muscle-growth peptides safe?
This is not a low-risk category. Several are research chemicals not approved for human use and of unknown purity, IGF-1 analogs raise a real cancer-promotion concern, and ACE-031 had its trials halted over safety signals. Anything in this space should be treated as experimental, not routine.
Are these peptides legal right now?
The compounded growth-hormone peptides like CJC-1295 are pending the FDA advisory review scheduled for July 23, 2026, so they are not legally compounded until guidance publishes. The others are sold as research chemicals, not as legitimate clinical products approved for human use.
Are peptides better than steroids or SARMs?
"Milder than steroids" is a marketing frame, not a safety rating. Anabolic steroids are controlled substances with serious risks, SARMs are unapproved with their own safety problems, and these peptides are largely unproven. None is a safe shortcut. The durable path is training, nutrition, sleep, and correcting genuine deficiencies under medical care.
What actually builds muscle?
Progressive resistance training, adequate protein, quality sleep, consistency, and time do the overwhelming majority of it. For people with a genuine deficiency, correcting it under a clinician, such as treating clinically low testosterone, can help. That is the high-yield, lower-risk path.
OneTwenty is a health technology company, not a medical provider, pharmacy, or laboratory. Clinical services are delivered by independent licensed providers, and OneTwenty does not prescribe medication. This article is educational and is not medical advice. Several of the compounds described are research chemicals that are not approved for human use and may be illegal to sell or possess for that purpose in your region. Talk to a qualified clinician before starting any peptide, hormone, or performance compound, especially if you are pregnant, breastfeeding, or managing a health condition.
Lifelong Optimization
Not your average
Checkup
Every life stage brings new biological demands. Tracking the right metrics at the right time helps you adapt, optimize performance, and extend both lifespan and healthspan.
Traditional
Manual Data Processing
Guesswork Trend Detection
Slow Campaign Setup
Multiple Tools, Multiple Logins
Reactive Decision-Making
Manual Reporting
Delayed Results
High Error Risk
Automated Data Sync
Real-Time Trend Insights
Instant AI Optimization
All-in-One Platform
Proactive AI-Driven Strategies
Auto-Generated Reports
Instant Performance Updates
AI Precision
Frequently Asked Questions
Clarity before
you commit
Answers on setup, scale, and support to remove blockers.
